Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Commonwealth Biotechnologies is struggling to prevent its...
Access Pharma revealed plans for a China clinical trial...
The Mimotopes China & VPSmart-DDS Biodelivery Centers...
GL Biochem, a Shanghai peptide company, has signed a...
Beijing announced a 10 billion RMB ($1.5 billion) fund to...
China-based biopharmas reported higher Q1 revenues...
Covering the BioBay Investor Forum 2008, Interfax...
AlphaRx and Venturepharm China, a subsidiary of...
Three life science companies will IPO on Shenzhen’s...
Although the ChinaBio® Index dropped during the...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China